{"id":29642,"date":"2025-07-01T10:53:26","date_gmt":"2025-07-01T10:53:26","guid":{"rendered":"https:\/\/www.europesays.com\/us\/29642\/"},"modified":"2025-07-01T10:53:26","modified_gmt":"2025-07-01T10:53:26","slug":"in-just-4-months-ai-medical-scribe-abridge-doubles-valuation-to-5-3b","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/29642\/","title":{"rendered":"In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B"},"content":{"rendered":"

Abridge, an AI startup automating medical notes<\/a>, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal<\/a>. The round, led by Andreessen Horowitz with participation from Khosla Ventures, follows the company\u2019s $250 million February fundraise<\/a> at a $2.75 billion valuation.<\/p>\n

The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry <\/strong>and integration with Epic Systems, the dominant health record software.<\/p>\n

In Q1, Abridge reached $117 million in contracted annual recurring revenue (a metric that includes all signed recurring contacts, including from customers that have still not been onboarded), The Information reported<\/a> last month.<\/p>\n

Along with the fundraise, Abridge announced that it is expanding into converting medical notes from patient appointments into AI-powered medical codes, an offering that makes the company directly competitive with startups like CodaMetrix and a feature from its partner Epic Systems<\/a>.<\/p>\n

Abridge, which was founded by cardiologist Shiv Rao, claims that its AI scribe technology is used by over 150<\/a> of the largest health systems in the U.S.<\/p>\n","protected":false},"excerpt":{"rendered":"Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion…\n","protected":false},"author":3,"featured_media":29643,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[17318,25400,25401,64,607,339,67,132,68],"class_list":{"0":"post-29642","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-entrepreneurship","8":"tag-a16z","9":"tag-abridge","10":"tag-ai-note-taking","11":"tag-business","12":"tag-entrepreneurship","13":"tag-in-brief","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114777607586250744","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/29642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=29642"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/29642\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/29643"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=29642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=29642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=29642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}